CORE LABS INC (CLB)
(Delayed Data from NYSE)
$19.07 USD
-0.14 (-0.73%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $19.06 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.07 USD
-0.14 (-0.73%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $19.06 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
Zacks News
EOG Resources Eyes Expansion in Ohio's Utica Shale Activity
by Zacks Equity Research
EOG plans to ramp up activity in Ohio's Utica shale play, doubling operations and positioning it as a key growth area for the company.
Transocean Secures $123 Million Offshore Drilling Contract in India
by Zacks Equity Research
RIG wins a 300-day drilling contract with Reliance Industries for the Dhirubhai Deepwater KG1 project in India, valued at approximately $123 million.
Core Laboratories (CLB) Loses -10.14% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Core Laboratories (CLB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Eni and Snam Advance CO2 Storage in Italy's Ravenna Project
by Zacks Equity Research
E and Snam kick off CO2 injection at Italy's first CCS project in Ravenna, setting the stage for significant emission reductions and driving industrial decarbonization.
Phillips 66 Divests Non-Core Natural Gas Assets in Texas Deal
by Zacks Equity Research
PSX offloads non-core natural gas assets in East Texas to Voyager Midstream, advancing its plan to generate $3 billion by 2024 through asset sales.
Making Sense of Delek US Holdings' $400M Stock Buyback Plan
by Zacks Equity Research
DK's latest repurchase expansion is supported by cash reserves of more than $650 million.
Transocean to Sell Two Drillships to Optimize Asset Portfolio
by Zacks Equity Research
RIG plans to sell the Development Driller III and Discoverer Inspiration drillships for $342 million, aiming to reduce debt and optimize its portfolio.
Equinor Shifts Focus to Boost Profit, Downsizes Renewables
by Zacks Equity Research
EQNR plans to downsize its renewables division, shifting its focus from growth to profitability amid industry challenges and rising costs.
ExxonMobil Aims to Take Full Control of Permian JV From Sinochem
by Zacks Equity Research
Acquiring the remaining stake in the Wolfcamp JV would reinforce XOM's leadership in the Permian Basin and provide strategic advantages amid the evolving global energy landscape.
Here's Why Core Laboratories (CLB) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BP to Produce Jet Fuel From Crops and Waste at Cherry Point
by Zacks Equity Research
BP's Cherry Point refinery is set to produce jet fuel from crops and waste, backed by a $27 million federal grant, creating jobs and boosting green aviation.
TechnipFMC's Stock Is Soaring, But Is It Time to Buy FTI?
by Zacks Equity Research
FTI's total backlog reached a historic high of $13.9 million in the second quarter of 2024.
Is CORE LABS INC (CLB) Stock Outpacing Its Oils-Energy Peers This Year?
by Zacks Equity Research
Here is how Core Laboratories (CLB) and Ranger Energy (RNGR) have performed compared to their sector so far this year.
Core Laboratories (CLB) Down 25.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
BKR or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BKR vs. CLB: Which Stock Is the Better Value Option?
Core Laboratories (CLB) Q2 Earnings Beat & Revenues Lag
by Zacks Equity Research
Core Laboratories (CLB) expects Reservoir Description revenues of $86.5-$89.5 million and Production Enhancement revenues of $44.5-$47.5 million for the third quarter of 2024.
Core Laboratories (CLB) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 4.76% and 1.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
FMC Technologies (FTI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
FMC Technologies (FTI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Core Laboratories (CLB) in Q2 Earnings?
by Zacks Equity Research
Core Laboratories (CLB) is expected to report higher revenues from the year-ago period's level. It is also likely to have incurred higher operating expenses.
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BKR or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BKR vs. CLB: Which Stock Is the Better Value Option?
Core Laboratories (CLB) Up 6.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates
by Zacks Equity Research
Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.
Kinder Morgan (KMI) Beats on Q1 Earnings, Hikes Dividend
by Zacks Equity Research
Kinder Morgan's (KMI) Q1 earnings gain from increased financial contributions from the Natural Gas Pipelines, Products Pipelines and Terminals business segments.
Sunoco (SUN) Proceeds With Strategic Portfolio Optimization
by Zacks Equity Research
Despite the significant structural changes, Sunoco (SUN) maintains its financial outlook for 2024. The company projects 2024 adjusted EBITDA between $975 million and $1 billion.